OZYMF
Orphazyme A/S

3
Loading...
Loading...
Strategic Partners A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Morkeberg Hinsby, Marja Jaattela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1

Frequently Asked Questions

What is Market Cap of Strategic Partners A/S?
What is the 52-week high for Strategic Partners A/S?
What is the 52-week low for Strategic Partners A/S?
What is Strategic Partners A/S stock price today?
What is the PE ratio of Strategic Partners A/S?
What is the Price-to-Book ratio of Strategic Partners A/S?
What is the 50-day moving average of Strategic Partners A/S?
How many employess does Strategic Partners A/S has?

Latest OZYMF News

View
No OZYMF news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.